- Home
- GXAI vs IRIX Comparison
GXAI vs IRIX Comparison
Compare GXAI & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GXAI
- IRIX
- Stock Information
- Founded
- GXAI 2021
- IRIX 1989
- Country
- GXAI United States
- IRIX United States
- Employees
- GXAI N/A
- IRIX 120
- Industry
- GXAI
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GXAI
- IRIX Health Care
- Exchange
- GXAI Nasdaq
- IRIX Nasdaq
- Market Cap
- GXAI 19.7M
- IRIX 22.4M
- IPO Year
- GXAI 2023
- IRIX 1996
- Fundamental
- Price
- GXAI $1.72
- IRIX $1.32
- Analyst Decision
- GXAI
- IRIX
- Analyst Count
- GXAI 0
- IRIX 0
- Target Price
- GXAI N/A
- IRIX N/A
- AVG Volume (30 Days)
- GXAI 15.2M
- IRIX 91.6K
- Earning Date
- GXAI 11-13-2025
- IRIX 11-11-2025
- Dividend Yield
- GXAI N/A
- IRIX N/A
- EPS Growth
- GXAI N/A
- IRIX N/A
- EPS
- GXAI N/A
- IRIX N/A
- Revenue
- GXAI $198,711.00
- IRIX $49,744,000.00
- Revenue This Year
- GXAI N/A
- IRIX $9.61
- Revenue Next Year
- GXAI N/A
- IRIX N/A
- P/E Ratio
- GXAI N/A
- IRIX N/A
- Revenue Growth
- GXAI 72158.55
- IRIX 0.09
- 52 Week Low
- GXAI $1.00
- IRIX $0.78
- 52 Week High
- GXAI $7.50
- IRIX $2.04
- Technical
- Relative Strength Index (RSI)
- GXAI 54.22
- IRIX 52.00
- Support Level
- GXAI $1.41
- IRIX $1.31
- Resistance Level
- GXAI $1.85
- IRIX $1.47
- Average True Range (ATR)
- GXAI 0.20
- IRIX 0.07
- MACD
- GXAI -0.03
- IRIX -0.00
- Stochastic Oscillator
- GXAI 32.98
- IRIX 40.00
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.